Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Irwin

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology GroupFlorette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Molecular and Cellular Biology|October 25, 2006
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snailAndrew J Evans, Ryan C Russell, Olga Roche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT ConsortiumSteven G DuBois, M Meaghan Granger, Susan Groshen, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
Chest|March 13, 2015
Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel ReportCynthia T French, Rebecca L Diekemper, Richard S Irwin, et al.
Journal of the National Cancer Institute|March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma PatientsPauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
Chest|April 10, 2015
Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel ReportAnne E Vertigan, Mohammad H Murad, Tamara Pringsheim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology GroupFlorette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Molecular and Cellular Biology|October 25, 2006
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snailAndrew J Evans, Ryan C Russell, Olga Roche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2021
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT ConsortiumSteven G DuBois, M Meaghan Granger, Susan Groshen, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
Chest|March 13, 2015
Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel ReportCynthia T French, Rebecca L Diekemper, Richard S Irwin, et al.
Journal of the National Cancer Institute|March 8, 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma PatientsPauline Depuydt, Valentina Boeva, Toby D Hocking, et al.
Journal of the National Cancer Institute|August 25, 2025
International neuroblastoma risk group consortium: a model of a networking for rare cancersSusan L Cohn, Wendy B London, Gudrun Schleiermacher, et al.
Chest|April 10, 2015
Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel ReportAnne E Vertigan, Mohammad H Murad, Tamara Pringsheim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2020
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe NeuroblastomaLucas Moreno, Giuseppe Barone, Steven G DuBois, et al.
Pageof 33